Literature DB >> 21461084

Delayed viral clearance of chronic hepatitis C in patients after treatment failure.

Su Hyun Cho1, Sung Wook Lee, Seok Reyol Choi, Sang Young Han, Myung Hwan Roh, Jong Hoon Lee, Jin Seok Jang, Yang Hyun Baek, Su Young Kim.   

Abstract

Hepatitis C virus (HCV) infection usually progresses to chronic hepatitis, with rare cases of spontaneous viral eradication. We present herein four cases involving patients that were initially declared to have failed to respond to treatments, based on the presence of HCV RNA that was still detectable after completion of the standard treatment for chronic hepatitis C with genotype 2. However, the HCV RNA became undetectable, with a delayed response, after discontinuation of therapy. Two of the four patients were diagnosed as treatment failures after extended treatment, and the other two received no further treatment after the standard treatment. All four patients maintained a sustained virological response during the periodic follow-up after delayed viral clearance.

Entities:  

Keywords:  Chronic hepatitis C; Delayed viral clearance; Sustained virological response

Year:  2011        PMID: 21461084      PMCID: PMC3065086          DOI: 10.5009/gnl.2011.5.1.110

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  18 in total

1.  Spontaneous elimination of serum HCV-RNA after total gastrectomy for early gastric cancer in a patient with chronic hepatitis C.

Authors:  M Yoshikawa; Y Morimoto; A Shiroi; H Yoshiji; S Kuriyama; H Fukui
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

2.  Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.

Authors:  P Fialaire; C Payan; D Vitour; J M Chennebault; J Loison; E Pichard; F Lunel
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

3.  Spontaneous clearance of chronic hepatitis C during pregnancy.

Authors:  C O Zein; H Abu-Lebdeh; N N Zein
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

4.  Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection.

Authors:  P Wietzke; P Schott; F Braun; S Mihm; G Ramadori
Journal:  Liver       Date:  1999-08

5.  Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment.

Authors:  Yang Hyun Baek; Sung Wook Lee; Hyun Seung Yoo; Hyun Ah Yoon; Ja Won Kim; Young Hoon Kim; Ha Youn Kim; Sang Young Han
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

6.  Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years.

Authors:  O Yokosuka; H Kojima; F Imazeki; M Tagawa; H Saisho; S Tamatsukuri; M Omata
Journal:  J Hepatol       Date:  1999-09       Impact factor: 25.083

7.  Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

Authors:  Gary L Davis; John B Wong; John G McHutchison; Michael P Manns; Joann Harvey; Janice Albrecht
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

8.  Persistent transaminase elevations in chronic hepatitis C patients with virological response during peginterferon and ribavirin therapy.

Authors:  Wen-Pang Su; Cheng-Yuan Peng; Hsueh-Chou Lai; Kuan-Fu Liao; Wen-Hsin Huang; Po-Heng Chuang; Chih-Bin Chen; Long-Bin Jeng
Journal:  Hepatogastroenterology       Date:  2009 May-Jun

Review 9.  Optimizing outcomes in patients with hepatitis C virus genotype 2 or 3.

Authors:  Thomas Berg; Giampiero Carosi
Journal:  Antivir Ther       Date:  2008

10.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

View more
  2 in total

1.  Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b.

Authors:  Akira Sato; Toshiya Ishii; Kayo Adachi; Hideaki Takahashi; Fumiaki Sano; Nobuyuki Matsumoto
Journal:  Case Rep Gastroenterol       Date:  2016-08-09

2.  Modeling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agents.

Authors:  Subhasish Baral; Rahul Roy; Narendra M Dixit
Journal:  Immunol Cell Biol       Date:  2018-06-05       Impact factor: 5.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.